ACONW stock

Is Aclarion Inc (ACONW) overvalued? · rev $45.7K

Aclarion Inc (ACONW) is a health information services company listed on US.

This page asks whether Aclarion Inc (ACONW) looks expensive on cached numbers — not a short thesis.

Latest reported ACONW revenue for 2024-12-31 was $45.7K. Net income was -$7.0M. Revenue was down 39.4% from 2023-12-31 to 2024-12-31. ACONW currently screens at market cap $0.

ACONW currently screens at market cap $0. A high multiple can be growth prepaid or a bubble. The filing has to explain the gap.

If the next ACONW 8-K cuts growth or raises capex, this “expensive” read gets worse. Until then the SEC page is the source.

Not investment advice. Use the ACONW stock page for the full model, not this heading.

Not investment advice.

Full ACONW analysis